Ekso Bionics (NASDAQ:EKSO) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Ekso Bionics (NASDAQ:EKSO) in a research report sent to investors on Friday. The brokerage issued a hold rating on the stock.

EKSO has been the topic of several other reports. Lake Street Capital decreased their price target on shares of Ekso Bionics from $2.50 to $2.00 and set a “buy” rating on the stock in a research note on Tuesday, October 29th. HC Wainwright reaffirmed a “buy” rating and set a $9.00 target price on shares of Ekso Bionics in a report on Tuesday, January 14th.

Ekso Bionics Stock Performance

EKSO opened at $0.53 on Friday. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.81 and a quick ratio of 2.14. The business has a fifty day simple moving average of $0.65 and a 200 day simple moving average of $0.89. Ekso Bionics has a 1 year low of $0.47 and a 1 year high of $2.32. The company has a market capitalization of $11.55 million, a PE ratio of -0.81 and a beta of 1.46.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.